TP53 and hepatocellular carcinoma: Secondly, human HCC exhibits remarkable heterogeneity, characterized by diverse genetic mutations (e.g., TP53, CTNNB1) and epigenetic modifications, whereas animal models relying on single cell lines or genetically engineered mice cannot adequately recapitulate this complexity (42).